Eli Lilly’s Diabetes Treatment Gains FDA Approval

Eli Lilly, facing generic competition that has damped the sales of some former blockbuster drugs, received positive news from the FDA this week. The regulatory agency announced Sept. 18 its decision to approve Trulicity (dulaglutide), a once-weekly injection to treat…

Health Technology (HIT)


Corporate news

FDA advisory committee

Gilead Sets Licensing Deals That Expand Global Access to HCV Treatments

Gilead Sciences has taken a big step toward addressing the public health issue of hepatitis C in developing countries around the world. Earlier this week, Gilead announced that it has signed non-exclusive licensing agreements with seven India-based generic pharmaceutical manufacturers…